Oscar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on December 29, 2023, reporting events occurring on December 28, 2023. The filing details the entry into a material definitive agreement regarding the company's credit facilities.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring rather than operational performance metrics such as revenue or profit. Key debt terms updated in this filing include:
- Revolving Loan Facility Commitment: Decreased to $115,000,000.
- Maturity Date: Extended to December 28, 2025.
- Expansion Option: The company retains the ability to increase commitments by up to $50,000,000 subject to conditions.
- Interest Rates: Floating rates based on adjusted term SOFR plus 4.50% or an alternative base rate plus 3.50%.
The filing text does not provide current values for revenue, profit, cash flow, margins, or total outstanding debt balances.
Material Changes Versus Prior Period
The primary material change is the amendment of the Credit Agreement originally dated February 21, 2021 (previously amended in January 2022 and July 2023). The specific changes include:
- Extension of the revolving loan facility maturity by approximately two years.
- Reduction of total available commitments under the facility.
- Retention of pricing terms substantially similar to the prior agreement.
Guidance, Risks, and Covenants
The Amended Credit Agreement imposes specific financial covenants that the company must maintain. Failure to meet these thresholds could constitute a default. Required covenants include:
- Direct Policy Premiums: Must not fall below certain quarterly thresholds.
- Medical Loss Ratio (MLR): Year-to-date MLR must not exceed certain thresholds.
- Adjusted EBITDA: Year-to-date consolidated adjusted EBITDA must not fall below certain thresholds.
- Liquidity: Must maintain liquidity equal to total revolving commitments less $50,000,000. If the facility is drawn by more than 60%, this test applies monthly rather than quarterly.
The filing does not contain forward-looking guidance on revenue or earnings, nor does it disclose specific risk factors beyond the covenant requirements.
Investor Verification Checklist
- Verify the current outstanding balance on the Revolving Loan Facility to assess immediate liquidity needs.
- Review the most recent quarterly report (10-Q) to confirm compliance with the new Medical Loss Ratio and Adjusted EBITDA thresholds.
- Confirm the company's current liquidity position against the covenant requirement (Total Commitments minus $50 million).
- Examine the full text of Exhibit 10.1 (Third Amendment to Credit Agreement) for specific numerical thresholds omitted from this summary.